The results to date with risperidone indicate that it may have both antipsychotic and mood-stabilizing properties. Despite the limitations of the open-label design, the results indicate that risperidone is a safe and effective therapy in combination with mood-stabilizers for the treatment of patients with manic, hypomanic, and depressive symptoms of mixed episodes in schizoaffective disorder, bipolar type.
Eduard Vieta, José Manuel Goikolea, Bàrbara Corbella, Antonio Benabarre, María Reinares, G. Martínez, Antonio García Fernández, Francesc Colom, Anabel Martínez‐Arán
Discussion(0)
No comments yet. Be the first to comment.